Merck
CN
  • Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma.

Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma.

Journal of pharmaceutical and biomedical analysis (2004-12-29)
P Pfuhl, U Kärcher, N Häring, A Baumeister, Mona Abdel Tawab, M Schubert-Zsilavecz
摘要

A sensitive, specific, accurate, and reproducible HPLC/MS-method for the simultaneous quantitative determination of niacin (NA) and its main metabolites niacinamide (NAM) and nicotinuric acid (NUR) in human plasma using chinolin-3-carboxylic acid as an internal standard was developed and validated according to international guidelines for method validation. All analytes and the internal standard were separated from acidified plasma by solid phase extraction. Afterwards the extracted samples were analyzed by HPLC/MS in the positive electrospray ionization mode (ESI) and selected ion monitoring (SIM). The total run time was 7 min between injections. The assay had a lower limit of quantification of 50.0 ng/mL for each analyte using 1 mL of plasma. The calibration curves were linear in the measured range between 50.0 and 750 ng/mL plasma. The overall precision and accuracy for all concentrations of quality controls and standards was better than 15%. No indications were found for possible instabilities of niacin, niacinamide and nicotinuric acid in plasma at -20 degrees C, in the extraction solvent or after repeated thawing/freezing cycles. In stabilities were observed in whole blood and in plasma at room temperature. The recovery of the extraction method ranged from 86 to 89% for the three analytes.

材料
货号
品牌
产品描述

Supelco
烟酰胺, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
烟酰甘氨酸